Prescription Drug Prices Record Largest Annual Drop in 60 Years — White House

Prescription Drug Prices Record Largest Annual Drop in 60 Years — White House

Prescription drug prices recorded their largest annual decline since 1963, with prices falling every month of 2026, according to White House data.

The administration attributes the decline to Most Favored Nation pricing. Under the policy, 26 of the world's largest drugmakers — covering 90 percent of the branded U.S. market — agreed to bring U.S. prices in line with the lowest paid by comparable developed nations. The agreements are projected to save Americans more than $600 billion.

For related coverage on health care costs, see our article on why Americans pay for insurance and still get hit with medical bills.

What the Data Shows

Prescription drug prices are down 3.9 percent since Trump took office. Nonprescription drugs are down 2.4 percent. Medical care commodities are down 2.7 percent.

The TrumpRx platform has generated $700 million in savings. GLP-1 medications that once cost over $1,000 a month start as low as $149. Fertility drugs, inhalers, insulin, and cholesterol treatments have been slashed 50 to 90 percent.

All 50 states, D.C., and Puerto Rico now get Most Favored Nation drug prices through Medicaid, unlocking nearly $65 billion in savings over the next decade.

For more on drug pricing and healthcare policy, read our coverage of how healthcare costs so much and still leaves patients paying out of pocket.

Why This Drop Is a Big Deal

Americans have been paying the highest prescription drug prices in the developed world for decades. The same drugs that cost $100 in Canada or $80 in Germany often cost $300 or more in the U.S. — sometimes double or triple what other countries pay.

The Most Favored Nation policy changes that math. Instead of letting drugmakers set whatever price the U.S. market will bear, the government now anchors U.S. prices to the lowest price paid by comparable developed nations. That means if a drug costs $50 in France, it can't cost $400 here.

The early numbers suggest it's working. Prices have fallen every single month of 2026. That's the longest sustained decline since 1963 — over 60 years.

What This Means for Your Wallet

If you're one of the millions of Americans who takes prescription medication, here's what this actually means:

GLP-1 medications: Drugs like Ozempic and Wegovy that were priced over $1,000 a month now start as low as $149. That's a massive difference for people managing diabetes or obesity.

Insulin: Prices have been slashed by 50 to 90 percent. For diabetics who need insulin to survive, this is life-changing.

Inhalers: Asthma patients who were paying hundreds of dollars per inhaler are now seeing similar cuts.

Fertility drugs: The cost of fertility treatments just dropped significantly, opening access to more families.

Cholesterol medications: Statins and other cholesterol treatments are also down, helping millions of Americans manage heart health at lower cost.

TrumpRx, the platform launched to give consumers direct access to discounted prices, has already generated $700 million in savings. That's real money back in people's pockets.

Medicaid Expansion: 50 States Plus D.C. and Puerto Rico

One of the biggest wins in this policy is Medicaid. All 50 states, Washington D.C., and Puerto Rico now get Most Favored Nation drug prices through Medicaid. That unlocks nearly $65 billion in savings over the next decade.

Medicaid covers millions of low-income Americans, including children, pregnant women, seniors in nursing homes, and people with disabilities. Lower drug prices through Medicaid mean more money for other critical services and less strain on state budgets.

The Skepticism — And Why It Matters

Not everyone is convinced the savings will stick. Critics point out that drugmakers raised prices on more than 350 prescription drugs early in the year, with a median hike of around 4 percent. Some individual prices doubled or more.

Pharmacy Benefit Managers (PBMs) are also under fire. These middlemen negotiate drug prices between manufacturers, insurance companies, and pharmacies. Critics say they drive up retail costs and squeeze local pharmacies out of business.

And there's always the question of whether price controls will stifle innovation. Drugmakers argue that lower prices mean less money for research and development. Supporters counter that drug companies spend more on marketing than R&D and that Americans have been subsidizing the rest of the world's drug prices for too long.

The data so far suggests the policy is working. Prices are down, savings are real, and consumers are seeing relief. But the long-term effects — on innovation, on drug availability, on the overall healthcare system — will take years to fully understand.

How to Find the Best Drug Prices

Even with prices falling, it still pays to shop around. Here are some strategies that can save you even more:

Compare cash-pay vs. insurance co-pay. Sometimes the cash price is lower than your insurance co-pay. Always ask the pharmacist for both prices.

Use discount cards. GoodRx, SingleCare, and similar tools can unlock lower prices at participating pharmacies.

Check manufacturer patient assistance programs. Many drugmakers offer direct assistance to patients who can't afford their medications.

Try warehouse club pharmacies. Costco, Sam's Club, and similar stores often have lower prescription prices than traditional pharmacies.

Ask about generic alternatives. Generics are almost always cheaper than brand-name drugs and work the same way for most patients.

Frequently Asked Questions